CN101810851A - Fibroblast growth factor (FGF) applied to treating blood streaks - Google Patents
Fibroblast growth factor (FGF) applied to treating blood streaks Download PDFInfo
- Publication number
- CN101810851A CN101810851A CN200910095936A CN200910095936A CN101810851A CN 101810851 A CN101810851 A CN 101810851A CN 200910095936 A CN200910095936 A CN 200910095936A CN 200910095936 A CN200910095936 A CN 200910095936A CN 101810851 A CN101810851 A CN 101810851A
- Authority
- CN
- China
- Prior art keywords
- growth factor
- fibroblast growth
- fgf
- compositions
- red blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to a composite containing a fibroblast growth factor (FGF). The composite has the action of treating blood streaks.
Description
Technical field
The present invention relates to a kind of compositions that comprises fibroblast growth factor (FGF) composition, be used for the treatment of red blood streak.
Background technology
Red blood streak claims face's telangiectasis again.Many facial skin horny layer are thinner, and blood capillary distributes more shallow, so, stimulating sensitivity especially to external world, red blood streak is easy to emersion.Sensitive skin is altered a great deal by climatic influences.Pollen dirt demodicid mite after the wind in spring, summer ultraviolet radiation, autumn drying and winter cold etc. all may cause skin allergy and red blood streak occurs, anaphylactogens such as various foods, medicine, metal, cosmetics all cause red blood streak in various degree probably, serious skin pruritus also can occur, the sense of burning, Hepar Sus domestica are red, play phenomenons such as measles, pigmentation.
Red blood streak mainly is that red blood trace on face patient face looks redder than the general normal colour of skin because of facial telangiectasis or the shallow facial phenomenon that causes of a part of blood capillary location tables, and what have only is that both sides cheekbone portion is rubescent, and the border is rounded.This skin is thin and responsive, and face is redder when supercool, overheated, excited.Severe patient also can form deposition property mottle, is difficult to cure, and not only influences the beauty of appearance, also can cause shade to psychology, to bringing great inconvenience orthobiosis.
Fibroblast growth factor (Flibroblast growth factor, FGF) be the peptide matters of the extensive biologic activity of a class tool, extracted from the cow brain tissue leachate by Gospodarowicz (1974) year the earliest, be the multipotency signaling molecule, participate in functions such as cell proliferation, differentiation and migration.The effect of FGF promoting growth of cell is very strong, and it has biological action widely, can influence growth, differentiation and the function of various kinds of cell., myocardial cell delicate, fibroblast, the thin fat of keratinization, neuron, astrocyte, follicle granulosa cell etc. as vascular endothelial cell, smooth muscle.FGF also is that important mitosis promotes the factor, also is that form takes place and the induced differentiation factor, participates in the repair process of growth promoter and tissue injury in normal physiological and pathological process.FGF is widely used in skin beauty treatment at present, FGF allow the skin delicacy, compact, pore refining, remove wrinkle and make that skin is young to truly have very outstanding effect aspect flexible.
Summary of the invention
The invention provides a kind of compositions that is used for the treatment of red blood streak, compositions contains the FGFs of effective dose.
FGF can repair damaged skin, rebuilds epithelium, dispels red blood streak, and moisturizing and skin rejuvenating recovers delicate beautiful skin, is applied to treat the red blood streak that facial telangiectasis causes.
The present invention preferably is prepared into the liquid preparation that contains FGF, also comprises simultaneously other external preparation type, as ointment etc.
Claims (5)
1. compositions for the treatment of red blood streak is characterized in that comprising the fibroblast growth factor (FGF) of effective dose.
2. compositions as claimed in claim 1 is characterized in that can be used for treating red blood streak.
3. compositions as claimed in claim 1, its fibroblast growth factor comprise people and mammiferous fibroblast growth factor, comprise people and various mammiferous whole FGF family members.
4. compositions as claimed in claim 1, its composition can contain a kind of FGF, also can contain multiple FGFs.
5. fibroblast growth factor as claimed in claim 3 comprises wild type fibroblast growth factor, recombinant type fibroblast growth factor and saltant fibroblast growth factor and their derivant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910095936A CN101810851A (en) | 2009-02-23 | 2009-02-23 | Fibroblast growth factor (FGF) applied to treating blood streaks |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910095936A CN101810851A (en) | 2009-02-23 | 2009-02-23 | Fibroblast growth factor (FGF) applied to treating blood streaks |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101810851A true CN101810851A (en) | 2010-08-25 |
Family
ID=42618312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910095936A Pending CN101810851A (en) | 2009-02-23 | 2009-02-23 | Fibroblast growth factor (FGF) applied to treating blood streaks |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101810851A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102268000A (en) * | 2011-05-05 | 2011-12-07 | 温州医学院 | Novel spiroheterocyclic compound and application of same serving as therapeutic agent |
-
2009
- 2009-02-23 CN CN200910095936A patent/CN101810851A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102268000A (en) * | 2011-05-05 | 2011-12-07 | 温州医学院 | Novel spiroheterocyclic compound and application of same serving as therapeutic agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104173251A (en) | Whitening mask containing yak ossein peptide and preparation method of whitening mask | |
| CN110755351A (en) | Whitening, moisturizing and repairing composition and application thereof | |
| CN105832613A (en) | All-effect repair water-optical skin-rejuvenating lotion | |
| CN108670901B (en) | Skin softening lotion with macadamia nut protein peptide and green tangerine peel extract as active ingredients and preparation method thereof | |
| CN101518508A (en) | Beautifying health composition and facial mask | |
| CN108524478A (en) | Purposes of the sanshool in preparing the external preparation for repairing dermal photodamage | |
| CN109549893A (en) | A kind of preparation method with anti-blue light contamination and the composition repaired and essence cream and its essence cream | |
| CN108078826A (en) | A kind of whitening and softening skin facial mask liquid and facial mask | |
| CN108261367A (en) | A kind of anti-aging moisturizing essence and preparation method thereof | |
| CN108815081A (en) | A kind of sericin whitening moisturizing face masque liquid and preparation method thereof | |
| CN113576975A (en) | Easily-absorbed anti-aging composition and preparation method and application thereof | |
| CN104000744A (en) | Hairdressing liquid capable of improving metabolism of skin and delaying senescence and production method of hairdressing liquid capable of improving metabolism of skin and delaying senescence | |
| CN108743921A (en) | It is a kind of to prevent the reparation liquid and its preparation method and application that scar is formed | |
| CN107898680A (en) | A kind of facial mask liquid and preparation method thereof and facial mask | |
| CN102228415B (en) | Composition containing tranexamic acid, and preparation method and uses thereof | |
| JP2008100943A (en) | External preparation for skin having action to promote secretion of insulin-like growth factor 1 | |
| CN103690393B (en) | Skin-whitening anti-wrinkle biological silk mask | |
| CN105101984B (en) | Ala-Gln, hyaluronic acid and oat extract synergistic combination and its for healing of wound and repair skin injury composition in purposes | |
| CN101810851A (en) | Fibroblast growth factor (FGF) applied to treating blood streaks | |
| WO2023030041A1 (en) | Type i collagen production accelerant | |
| CN105078862A (en) | Whitening and freckle removing facial mask and preparation method thereof | |
| CN105055187B (en) | A kind of face rejuvenation cosmetic formulation and preparation method thereof | |
| CN108355125A (en) | Anti- chap ointment of one kind and preparation method thereof | |
| CN103908416A (en) | Skincare active factor composition | |
| JP2023526854A (en) | Skin care products containing a protein matrix |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Dong Xueping Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| DD01 | Delivery of document by public notice |
Addressee: Dong Xueping Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100825 |